Transfusion in the management of patients with megaloblastic anaemia

M F McMullin, R J Cuthbert

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Transfusion has been associated with significant morbidity and mortality in megaloblastic anaemia (MA). This retrospective study was undertaken to examine the usefulness of transfusion in the management of MA. Fifty-two patients with MA were identified. Of the 20 transfused patients 13 were treated with diuretics and six with potassium supplements. The mean haemoglobin (Hb) of the transfused group was 6.5 g/dl (range 4.8-10.4 g/dl), and of the 32 non-transfused patients 10.5 g/dl (range 5.6-17.0 g/dl). The Hb and packed cell volume (PCV) were significantly lower in the transfused group. Only two of 32 non-transfused group were given potassium supplements. In this small group of patients with MA, transfusion appeared to be safe and no complications of transfusion were identified. However, advice was not being followed. We would suggest that, although transfusion has a minor role in the management of MA, consideration must be given to the general hazards of transfusion.
Original languageEnglish
Pages (from-to)104-106
Number of pages3
JournalInternational Journal of Clinical Practice
Issue number2
Publication statusPublished - Mar 1999

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Transfusion in the management of patients with megaloblastic anaemia'. Together they form a unique fingerprint.

Cite this